Overall survival also extended with conjugate treatment In a small, phase II trial, patients with advanced gastric cancer were far more likely to respond to conjugate therapy with trastuzumab deruxtecan (Enhertu) than with...
Read More
When it comes to rates of infection and addiction, both the coronavirus pandemic and the opioid...
Read More
Majority of products in medicinal, recreational programs advertised to have >15 percent THC
Read More Differences identified in depression severity, symptom burden, and depression care
Read More
Today, a substantial proportion of medical cannabis users report using cannabis to manage headache...
Read More
The severity of osteoporosis in SMID started during the growth period and seems to be caused by a...
Read More
While the frequency of short-term side effects of opioids are well-known, the long-term risks of...
Read MoreMaintaining phosphorus balance in in-center hemodialysis (ICHD) patients is problematic despite recommended dietary restriction, dialysis, and phosphate binder use. Rarely is P content in prescribed medications considered, but...
Read MoreNaltrexone and nalmefene are approved for the treatment of alcohol use disorders, in different countries. Naltrexone is also approved for the treatment for opioid use disorders, most recently in a depot formulation. These...
Read More